Literature DB >> 29468280

[Pathology and histopathological evaluation of penile cancer].

A Erbersdobler1.   

Abstract

BACKGROUND: Penile cancer is rare in Germany and in western European countries. Our understanding of the pathogenesis and pathology of this malignancy has increased considerably in recent years.
OBJECTIVES: Clinical management has become more complex, with organ-preserving strategies being increasingly favored. Associated with these developments, the demands on the pathology reports of biopsies and surgical specimens from the penis have also increased.
MATERIALS AND METHODS: According to guidelines and the relevant literature, this review outlines the most important aspects that must be considered in the classification and pathological reporting of penile cancer.
RESULTS: Correct histological subtyping of penile cancer is important for prognostic and therapeutic considerations. There are also some peculiarities with the current TNM classification system of this tumor compared to other entities.
CONCLUSION: Handling of specimens and histopathological typing must be performed by experienced pathologists according to recent developments in the pathogenesis, classification, and therapeutic strategies of penile cancer.

Entities:  

Keywords:  Human papillomavirus; Malignancy; Neoplasms; Precancerous conditions; Squamous cell carcinoma

Mesh:

Year:  2018        PMID: 29468280     DOI: 10.1007/s00120-018-0592-8

Source DB:  PubMed          Journal:  Urologe A        ISSN: 0340-2592            Impact factor:   0.639


  26 in total

1.  Prognostic significance of extranodal extension in patients with pathological node positive penile carcinoma.

Authors:  Niels M Graafland; Hester H van Boven; Erik van Werkhoven; Luc M F Moonen; Simon Horenblas
Journal:  J Urol       Date:  2010-08-17       Impact factor: 7.450

Review 2.  Intraoperative frozen section diagnosis in urological oncology.

Authors:  F Algaba; Y Arce; A López-Beltrán; R Montironi; G Mikuz; A V Bono
Journal:  Eur Urol       Date:  2005-02       Impact factor: 20.096

3.  Expression of p53, p21 and cyclin D1 in penile cancer: p53 predicts poor prognosis.

Authors:  Sven Gunia; Christoph Kakies; Andreas Erbersdobler; Oliver W Hakenberg; Stefan Koch; Matthias May
Journal:  J Clin Pathol       Date:  2011-12-01       Impact factor: 3.411

4.  EAU guidelines on penile cancer: 2014 update.

Authors:  Oliver W Hakenberg; Eva M Compérat; Suks Minhas; Andrea Necchi; Chris Protzel; Nick Watkin
Journal:  Eur Urol       Date:  2014-11-01       Impact factor: 20.096

5.  HPV-negative penile squamous cell carcinoma: disruptive mutations in the TP53 gene are common.

Authors:  Karl Kashofer; Elke Winter; Iris Halbwedl; Andrea Thueringer; Marisa Kreiner; Stefan Sauer; Sigrid Regauer
Journal:  Mod Pathol       Date:  2017-04-07       Impact factor: 7.842

6.  The retinoblastoma protein/p16 INK4A pathway but not p53 is disrupted by human papillomavirus in penile squamous cell carcinoma.

Authors:  Elzbieta Stankiewicz; David M Prowse; Elena Ktori; Jack Cuzick; Laurence Ambroisine; Xiaoxi Zhang; Sakunthala Kudahetti; Nicholas Watkin; Catherine Corbishley; Daniel M Berney
Journal:  Histopathology       Date:  2011-02-16       Impact factor: 5.087

7.  What surgical resection margins are required to achieve oncological control in men with primary penile cancer?

Authors:  Suks Minhas; Oliver Kayes; Paul Hegarty; Pardeep Kumar; Alex Freeman; David Ralph
Journal:  BJU Int       Date:  2005-11       Impact factor: 5.588

Review 8.  The role of pathologic prognostic factors in squamous cell carcinoma of the penis.

Authors:  Antonio L Cubilla
Journal:  World J Urol       Date:  2008-09-03       Impact factor: 4.226

9.  Lichen sclerosus in 68 patients with squamous cell carcinoma of the penis: frequent atypias and correlation with special carcinoma variants suggests a precancerous role.

Authors:  Elsa F Velazquez; Antonio L Cubilla
Journal:  Am J Surg Pathol       Date:  2003-11       Impact factor: 6.394

10.  HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis.

Authors:  Elzbieta Stankiewicz; Sakunthala C Kudahetti; David M Prowse; Elena Ktori; Jack Cuzick; Laurence Ambroisine; Xiaoxi Zhang; Nicholas Watkin; Catherine Corbishley; Daniel M Berney
Journal:  Mod Pathol       Date:  2009-05-22       Impact factor: 7.842

View more
  3 in total

Review 1.  What you need to know: updates in penile cancer staging.

Authors:  Mahmoud I Khalil; Mohamed H Kamel; Jasreman Dhillon; Viraj Master; Rodney Davis; Ali J Hajiran; Philippe E Spiess
Journal:  World J Urol       Date:  2020-06-22       Impact factor: 4.226

2.  The Diagnosis and Treatment of Penile Cancer.

Authors:  Oliver Walther Hakenberg; Desiree Louise Dräger; Andreas Erbersdobler; Carsten Maik Naumann; Klaus-Peter Jünemann; Chris Protzel
Journal:  Dtsch Arztebl Int       Date:  2018-09-28       Impact factor: 5.594

3.  The Clinical Complexity of Penile Cancer: Current Clinical-Epidemiological Data from the Database of the Free State of Saxony/Germany.

Authors:  Wolf-Diether U Boehm; Daniela Piontek; Stefanie Latarius; Olaf Schoffer; Angelika Borkowetz; Stefanie J Klug; Manfred P Wirth
Journal:  Urol Int       Date:  2021-10-26       Impact factor: 1.934

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.